Patanjali Eyeing 4 IPOs in 5 Years
Patanjali Ayurved is an Indian multinational conglomerate holding company started by Baba Ramdev. In 2016, CLSA and HSBC recognised it as one of the fastest-growing FMCG brands in India. Currently, the group’s turnover is Rs 40,000 crore, with a market capitalisation of Rs 50,000 crore. Ramdev said he aims to take the group’s market capitalisation to Rs 5 lakh crore in five years, while the group’s turnover is expected to rise to Rs 1 lakh crore.
Patanjali Foods is the group’s only listed company, but its IPO did not come under Ramdev’s leadership and vision. In 2019, Patanjali Ayurved bought the listed company, Ruchi Soya, for Rs 4,350 crore under a resolution process.
After the announcement, the shares of Patanjali Foods started trading 0.6 per cent higher at Rs 1,351 on 16 September 2022 at 1 pm. The stock has already witnessed around a 60 per cent year-to-date rally, making Patanjali Foods one of the fastest-growing brands in India.
Ramdev did not share any timelines on when he will be listing Patanjali companies on the stock exchange. However, he stated that the journey of Patanjali Foods has begun to evolve as a diversified FMCG and FMHG-centred company with popular brands, such as Nutrela, Ruchi Soya, and Patanjali, across the value chain. The company is a market leader in the branded TSP (textured soya protein) sector with Nutrela. He also believes the company will surpass peers through portfolio diversification and the use of Patanjali Ayurved Limited’s strong distribution network.
During FY 2021-2022, the company’s revenue increased by 9% from Rs. 9,811 crore recorded the previous year to Rs 10,664.46 crore. However, the profit after taxes was slightly lower at Rs 740.38 crore from Rs 745.03 crore in FY 2020-2021. For FY 2021-2022, the revenue of the FMCG business rose to Rs 9,241 crore versus Rs 8,778 crore in FY 2020-2021. The ayurvedic products’ business also climbed to Rs 1,274 crore against Rs 925 crore a year ago.
Disclaimer: ICICI Securities Ltd.( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400025, India, Tel No : 022 - 2288 2460, 022 - 2288 2470. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code :07730) and BSE Ltd (Member Code :103) and having SEBI registration no. INZ000183631. Name of the Compliance officer (broking): Ms. Mamta Shetty, Contact number: 022-40701000, E-mail address: firstname.lastname@example.org. Investment in securities market are subject to market risks, read all the related documents carefully before investing. Composite Corporate Agent License No.CA0113, AMFI Regn. No.: ARN-0845. PFRDA registration numbers: POP no -05092018. We are distributors of Insurance and Mutual funds, IPOs, Corporate Fixed Deposits, NCDs, PMS and AIF products. We act as a Syndicate, Sub -syndicate member for IPO, FPO. Please note that Mutual Fund Investments are subject to market risks, read the scheme related documents carefully before investing for full understanding and detail. Past performance of the scheme does not guarantee future performance of the investment. ICICI Securities Ltd is the AMFI registered mutual fund distributor. ICICI Securities Ltd. does not underwrite the risk or act as an insurer. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon.
The non-broking products / services like demat, Mutual Funds, Insurance, IPOs, FD/ Bonds, loans, PMS, Tax, Elocker, NPS, IPO, Research, Financial Learning etc. are not exchange traded products / services and all disputes with respect to the distribution activity would not have access to Exchange investor redressal or Arbitration mechanism.